Evidence map›Paper›PMID 41800541›Full record

ArticleChronic respiratory disease

Global, regional and national trends in burden of chronic obstructive pulmonary disease from 2000 to 2021 and the prediction for 2030.

Jian Xu, Huiqing Xu, Dandan Zhang, Xiaojing Deng, Yeping Bian, Yunting Xu, Guofeng Ao, Jiannan Liu, Fei Xu

Abstract read
In one paragraph

Article in Chronic respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jian XuDepart of Intensive Care Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China.
Huiqing XuDepartment of Primary Healthcare, Nanjing Medical University Affiliated Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.
Dandan ZhangDepartment of Respiratory Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China.
Xiaojing DengDepart of Intensive Care Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China.
Yeping BianDepart of Intensive Care Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China.
Yunting XuDepartment of Primary Healthcare, Nanjing Medical University Affiliated Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.
Guofeng AoDepartment of Primary Healthcare, Nanjing Medical University Affiliated Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.
Jiannan LiuDepartment of Respiratory Medicine, Geriatric Hospital of Nanjing Medical University, Nanjing, China.
Fei XuDepartment of Primary Healthcare, Nanjing Medical University Affiliated Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.ORCID 0000-0003-1785-3635

Funding

Jiangsu Province Chinese Medical Science and Technique Development Foundation QN202223
6 · The paper itself

Abstract

AimsTo estimate the global burden of chronic obstructive pulmonary disease (COPD) by age, gender and socioeconomic status from 2000 to 2021, and make a prediction until 2030.MethodsData were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. The burden of COPD, referred to absolute numbers of COPD case and age-standardized rates (ASRs) per 100,000 individuals per year. The temporal trends from 2000 to 2021 were examined using Joinpoint models. Bayesian age-period-cohort models were introduced to project the burden until 2030. Finally, a decomposition analysis was conducted to reveal the contributions of aging, population growth and epidemiological changes to trends in COPD burden.ResultsThe crude numbers of incident cases, prevalent cases, deaths, and disability-adjusted life years (DALYs) for COPD remained increasing from 2000 to 2021, and until 2030, worldwide. ASRs of incidence, prevalence, deaths, and DALYs were in decreasing trends, and would continue to decline until 2030. Additionally, in 2021, the ASR of COPD burden was higher in males than females, while the age-specific rate increased with age. The disease burden varied across different regions, with a high burden in low development-level regions. The increasing burden of COPD was primarily driven by rapid aging and population growth.ConclusionsThe global ASRs of COPD burden would remain declining, but the crude burden would continue to increase until 2030. This study has public health implications for population-based interventions against COPD with consideration of residents' age, gender and residing area as well as economic status.

Indexed as

Global Burden of DiseaseGlobal HealthPulmonary Disease, Chronic ObstructiveAgedAged, 80 and overAge DistributionBayes TheoremDisability-Adjusted Life YearsFemaleForecastingHumansIncidenceMaleMiddle AgedPrevalenceSex Distributionchronic obstructive pulmonary diseasedeathsdisability-adjusted life yearsincidenceprevalence

Identifiers

PMID41800541
PMCPMC12972555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.